A study of oxidative stress and the newer antiepileptic drugs in epilepsy associated with severe motor and intellectual disabilities
| Autor: | Toshiaki Hashimoto, Masahito Morimoto, Shojiro Kyotani, Shigeko Satomura |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Adult
Male 030506 rehabilitation Pediatrics medicine.medical_specialty Adolescent Intractable epilepsy Lamotrigine medicine.disease_cause 03 medical and health sciences Epilepsy 0302 clinical medicine Pharmacotherapy Intellectual Disability medicine Humans oxidative stress antiepileptic drugs Motor Neuron Disease Child Adverse effect Response rate (survey) Medicine(all) lcsh:R5-920 children with disabilities business.industry General Medicine medicine.disease Anesthesia epilepsy Anticonvulsants Female Levetiracetam Reactive Oxygen Species 0305 other medical science business lcsh:Medicine (General) 030217 neurology & neurosurgery Oxidative stress medicine.drug |
| Zdroj: | Journal of the Chinese Medical Association, Vol 80, Iss 1, Pp 19-28 (2017) |
| ISSN: | 1726-4901 |
| DOI: | 10.1016/j.jcma.2016.10.005 |
| Popis: | Background Patients with severe motor and intellectual disabilities (SMID) are those who have both severe intellectual disabilities and severe physical disabilities. Intractable epilepsy is often associated with SMID. The purpose of this study was to elucidate the relationship between epilepsy associated with SMID and oxidative stress, and to clarify the safety and efficacy of the newer antiepileptic drugs (newer AEDs), lamotrigine and levetiracetam. Methods This study was conducted in 27 SMID patients with epilepsy who were treated with the newer AEDs. The patient characteristics and the safety and efficacy of the newer AEDs were investigated. The reactive oxygen metabolite (d-ROM) and biological antioxidant potential (BAP) levels were measured as indicators of the degree of oxidative stress. The relationship between the investigation results (the patient characteristics, and the safety and efficacy of the newer AEDs) and the results of measurements of the d-ROMs/BAP were analyzed. Results All the patients who discontinued the newer AEDs had abnormal plasma d-ROM levels. In addition, all the patients who developed adverse events also had abnormal d-ROM levels. Furthermore, there was a trend toward a lower response rate in patients with higher plasma d-ROM levels. Conclusion The results of this study suggested that d-ROM levels are useful for predicting the safety and efficacy of the newer AEDs (lamotrigine, levetiracetam) in SMID patients with intractable epilepsy. Therefore, d-ROMs could be important biomarkers for determining the safety and efficacy of drug therapy in SMID patients with epilepsy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|